News Archives - Page 3 of 54

News

Corbus Pharmaceuticals Reports Last Subject Visit in RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis

Topline data on schedule for summer 2020Systemic sclerosis (SSc) is a rare, serious and life-threatening autoimmune disease affecting ~200,000 people in the U.S., EU and JapanThere are no FDA-approved therapies…

View Post

News

Arbutus to Present at Jefferies Virtual Healthcare Conference

WARMINSTER, Pa., May 27, 2020 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company focused on developing a cure for people with chronic hepatitis B virus (HBV)…

View Post

News

Assembly Biosciences Announces Management Transition

— Expert Virologist and Biologist William Delaney, PhD joins as Chief Scientific Officer, Virology — — EVP and CSO of Virology Operations Richard Colonno, PhD to retire — SOUTH SAN FRANCISCO,…

View Post

News

Neoleukin Therapeutics to Present at Jefferies Virtual Healthcare Conference

SEATTLE, May 27, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that Jonathan Drachman, M.D., Chief…

View Post

News

Corvus Pharmaceuticals to Present at the Jefferies 2020 Virtual Healthcare Conference

BURLINGAME, Calif., May 27, 2020 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies and the utilization…

View Post

News

Bellicum to Participate in Two Upcoming Virtual Investor Conferences

HOUSTON, May 27, 2020 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that management will participate in two upcoming…

View Post

News

MacroGenics Announces Registration Study of Flotetuzumab in Patients with Refractory Acute Myeloid Leukemia

Rockville, MD, May 27, 2020 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer,…

View Post

News

Cytokinetics and The ALS Association Renew Partnership to Advance the Fight Against ALS

SOUTH SAN FRANCISCO, Calif., and WASHINGTON, May 27, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq:CYTK) and The ALS Association today announced the continuation of their partnership in the fight against…

View Post

News

Amunix Appoints Anne Keane as Senior Vice President of Regulatory and Quality

MOUNTAIN VIEW, Calif., May 27, 2020 (GLOBE NEWSWIRE) — Amunix Pharmaceuticals, Inc. (“Amunix”), a biopharmaceutical company focused on developing prodrugs to bring the promise of potent immune-activating biotherapeutics to patients…

View Post

News

Illegal Online Pharmacies Exploit Vulnerable Consumers During the COVID-19 Pandemic

MOUNT PROSPECT, IL, May 26, 2020 (GLOBE NEWSWIRE) — The National Association of Boards of Pharmacy® (NABP®) released the May 2020 Rogue Rx Activity Report, Rogue Online Pharmacies in the Time of…

View Post